Ensuring the safety and quality of cosmetic products is not optional—it is essential. ISO 22716 provides comprehensive Good Manufacturing Practices (GMP) guidelines governing the manufacturing, quality control, storage, and distribution of cosmetic products in a controlled and professional manner. By implementing ISO 22716, organizations ensure compliance with international regulations, reduce health risks to consumers, and strengthen market trust. ISO 22716 is more than a standard—it is the foundation for building a safe, credible cosmetic brand ready to compete in the global market.

The pharmaceutical industry cannot afford compromise—drug safety, quality, and regulatory compliance are non-negotiable. GMP (Good Manufacturing Practices / CPOB) ensures every step of production runs consistently, hygienically, and under strict control, keeping product quality intact from manufacture to market. Implementing GMP not only ensures compliance with national and international regulations but also earns market trust, strengthens brand reputation, and unlocks global distribution opportunities. GMP is the key to demonstrating credibility and maintaining a competitive edge in the pharmaceutical industry.

Ensuring the quality, safety, and efficacy of medicines until they reach consumers is a top priority for every pharmaceutical company. CDOB (Good Distribution Practices for Medicines) sets comprehensive standards covering quality management, personnel, facilities, operations, and self-inspections, guaranteeing that medicines remain safe and effective throughout the supply chain. By implementing CDOB, organizations not only comply with BPOM RI regulations but also protect the public, prevent counterfeit products, and strengthen brand reputation. CDOB is a strategic investment that builds market trust, reinforces business credibility, and establishes your company as a professional and reliable leader in the pharmaceutical industry.

In the healthcare industry, medical device and household health product manufacturers cannot afford compromise—compliance, quality, and safety are non-negotiable. CPAKB (Good Manufacturing Practices for Medical Devices and Household Health Products) ensures every step from production to distribution runs consistently, safely, and fully in line with Ministry of Health Regulation No. 20 of 2017. Implementing CPAKB is a legal requirement—it is a clear demonstration of your company’s commitment to product quality, safety, and efficacy, while meeting regulatory obligations and building unshakable consumer trust. With CPAKB, your organization establishes itself as a professional, reliable industry leader, ready to dominate national and global markets.

The quality and safety of medical devices must be consistently safeguarded throughout the entire distribution chain, ensuring they remain reliable, safe, and ready for use by healthcare professionals and patients. True excellence is not defined by the product alone, but by a distribution system that upholds precision, integrity, and trust. Through Ministry of Health Regulation No. 4 of 2014, the Indonesian Ministry of Health mandates medical device distributors to implement standardized distribution practices as a prerequisite for market authorization. This standard, known as CDAKB (Good Distribution Practice for Medical Devices), governs every critical stage—from ordering and storage to transportation and delivery—ensuring each product reaches its destination in optimal condition and uncompromised quality.